Aptiv PLC (APTV) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-30

Key Insights

Director Hakan Agnevall acquired 3,086 restricted stock units (RSUs) on 04/29/2026 vesting before the 2027 Annual Meeting, representing compensation rather than discretionary insider buying activity.
On 04/28/2026, Agnevall disposed of 271 shares at $59.12 through a tax withholding transaction related to RSU vesting, a routine administrative action typical for equity compensation.
Total beneficial ownership adjusted to 7,597 shares post-transactions, reflecting the impact of Versigent PLC spin-off on outstanding awards, indicating capital structure changes affecting insider holdings.
The absence of open market purchases or significant accumulation suggests the director is not demonstrating strong conviction in the stock's near-term prospects through discretionary buying.

Want the newest filings?

This analysis covers the filing from 2026-04-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-30

Director Ana G. Pinczuk executed a tax-related stock sale on 04/28/2026, selling 287 shares at $59.12 per share, which appears to be shares withheld for tax liabilities from RSU vesting rather than a discretionary sale.
Pinczuk received 3,086 restricted stock units on 04/29/2026 with no purchase price, indicating equity compensation that will vest one day before the 2027 Annual Meeting of Shareholders.
Total beneficial ownership reflects a post-spin-off adjustment related to the Versigent PLC spin-off, with current direct ownership of 10,228 shares plus 15,561 shares held indirectly through the Vaziri Pinczuk Living Trust.
The filing shows routine insider equity compensation and tax-driven share transactions with no evidence of substantial discretionary buying or selling, suggesting neutral confidence from this director regarding stock valuation.

Filed: 2026-04-30

Director Colin J. Parris sold 306 ordinary shares on 04/28/2026 at $59.12 per share, totaling approximately $18,090, which represents a modest disposal likely for tax withholding purposes related to RSU vesting.
Parris acquired 3,292 restricted stock units on 04/29/2026 with no monetary value, vesting one day before the 2027 Annual Meeting of Shareholders, indicating continued equity compensation alignment with shareholder interests.
Post-transaction beneficial ownership stands at 22,791 ordinary shares (direct), reflecting a net increase of 2,986 shares after accounting for the sale and RSU acquisition, suggesting confidence in the company's direction despite the share disposal.
The filing notes an adjustment to outstanding awards resulting from the Versigent PLC spin-off, indicating recent corporate restructuring activity that affects share count calculations and insider holdings.

Filed: 2026-04-30

Director Robert K. Ortberg sold 287 ordinary shares on 04/28/2026 at $59.12 per share, likely for tax withholding obligations related to restricted stock unit vesting rather than a voluntary sale decision.
Ortberg received 3,086 restricted stock units (RSUs) on 04/29/2026 with no monetary cost, vesting one day before the 2027 Annual Meeting of Shareholders, indicating continued executive compensation alignment with shareholders.
Total beneficial ownership increased from 16,362 to 19,448 shares following these transactions, with the net gain of 2,799 shares reflecting RSU vesting that outweighs the tax-motivated share sale.
The filing reflects adjustments to outstanding awards due to the Versigent PLC spin-off, suggesting recent corporate restructuring that may have impacted share counts and equity compensation calculations.

Filed: 2026-04-30

Director Paul M. Meister sold 590 shares on 04/28/2026 at $59.12 per share, likely for tax withholding obligations related to vesting restricted stock units rather than a discretionary sale.
Meister acquired 6,344 restricted stock units on 04/29/2026 with no monetary consideration, vesting just before the 2027 Annual Meeting of Shareholders, indicating standard equity compensation practice.
Total beneficial ownership increased to 13,612 direct shares following the transactions, with an additional 19,181 shares held indirectly through the Paul M. Meister 2005 Revocable Trust, demonstrating substantial stake in the company.
The filing reflects adjustment of awards due to the spin-off of Versigent PLC, suggesting corporate restructuring activity that may impact share counts across Aptiv's cap table.

Filed: 2026-04-30

Director Sean O. Mahoney sold 408 ordinary shares on 04/28/2026 at $59.12 per share, likely to satisfy tax withholding obligations from restricted stock unit vesting rather than indicating negative sentiment about the company.
Mahoney received 3,292 restricted stock units on 04/29/2026 with no monetary consideration, vesting before the 2027 Annual Meeting, demonstrating continued equity compensation alignment with shareholders.
Total beneficial ownership increased from 17,222 to 20,514 shares following the transactions, reflecting a net gain of 3,292 shares attributable to RSU vesting, adjusted for the Versigent PLC spin-off.
The timing of the share sale immediately following RSU vesting (tax withholding pattern) and receipt of new RSUs suggests routine equity compensation management rather than any directional trading signal.

Filed: 2026-04-30

Director Merit E. Janow sold 287 shares at $59.12 on 04/28/2026, representing a modest insider sale that does not indicate significant bearish sentiment given the small transaction size relative to total holdings.
Janow received 3,086 restricted stock units (RSUs) on 04/29/2026 vesting before the 2027 Annual Meeting, demonstrating continued executive compensation and confidence in the company's future performance.
Total beneficial ownership increased from 10,718 to 13,804 shares following the RSU grant and Versigent PLC spin-off adjustment, indicating the director maintains a meaningful equity stake in Aptiv despite the modest share sale.
The spin-off of Versigent PLC required adjustment to outstanding awards, suggesting organizational restructuring that may impact future compensation structures and executive alignment with shareholders.

Filed: 2026-04-30

Director Vasumati P. Jakkal sold 383 ordinary shares on 04/28/2026 at $59.12 per share, likely for tax withholding purposes related to restricted stock unit vesting rather than a discretionary sale.
The reporting person received 4,115 restricted stock units on 04/29/2026 with no monetary value, representing compensation that will vest one day before the 2027 Annual Meeting of Shareholders.
Total beneficial ownership increased from 7,934 to 12,049 shares following the transactions, reflecting a net gain of 4,115 shares after the RSU grant and tax withholding.
Outstanding awards were adjusted downward due to the spin-off of Versigent PLC, indicating a corporate restructuring event that affected share count calculations for insider holdings.

Filed: 2026-04-30

Director Joseph L. Hooley sold 518 ordinary shares on 04/28/2026 at $59.12 per share, likely for tax withholding purposes related to RSU vesting rather than a discretionary sale decision.
Hooley acquired 5,572 restricted stock units on 04/29/2026 with zero exercise price, vesting one day before the 2027 Annual Meeting of Shareholders, indicating standard long-term equity compensation aligned with shareholder interests.
Post-transaction beneficial ownership reflects adjustments from the Versigent PLC spin-off, with total ordinary shares held at 27,869 after both transactions, showing sustained significant stake in the company despite recent corporate restructuring.
The net acquisition of shares (5,572 RSUs granted minus 518 shares sold) suggests insider confidence, though the modest transaction size and routine nature of RSU vesting limit the significance as a positive signal.

Filed: 2026-04-30

Director Nancy E. Cooper executed a net increase in beneficial ownership, acquiring 3,395 restricted stock units (RSUs) on 04/29/2026 while selling 316 shares on 04/28/2026 for tax withholding purposes, resulting in total beneficial ownership of 20,406 shares.
The RSU grant vests one day before the 2027 Annual Meeting of Shareholders, indicating equity compensation aligned with standard long-term incentive plan practices rather than opportunistic insider trading.
Share count adjustments reflect the recent spin-off of Versigent PLC, which reduced Cooper's total holdings from approximately 17,011 to 20,406 shares after the corporate reorganization.
The stock price at transaction was $59.12, and the acquisition of RSUs at $0.00 represents non-discretionary compensation rather than a bullish insider buy signal suggesting undervaluation.

Filed: 2026-04-01

Aptiv PLC has distributed all of its ordinary shares of Versigent PLC to its shareholders, effectively spinning off the Versigent business.
The spin-off transaction occurred on April 1, 2026, with the record date for the distribution being March 17, 2026.
As a result of the spin-off, Aptiv PLC no longer owns any shares of Versigent PLC, which is now an independent publicly traded company.

Other reports for Aptiv PLC

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.